Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antisense oligonucleotides: A promising advancement in neurodegenerative disease treatment

24 Apr 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetics and Neurodevelopmental Disorders
Share to Neurogenetic and Muscular Disorders Research
Share to RNA Interference and Gene Delivery

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40287045
DOI: 10.1016/j.ejphar.2025.177644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antisense oligonucleotides: A promising advancement in neurodegenerative disease treatmentPMID 40287045Read ↗

The expanding application of antisense oligonucleotides to neurodegenerative diseasesSemantic proximity Read ↗

Antisense oligonucleotides: the next frontier for treatment of neurological disordersSemantic proximity Read ↗

Antisense Oligonucleotides: Treating Neurodegeneration at the Level of RNASemantic proximity Read ↗

Oligonucleotide-based therapy for neurodegenerative diseasesSemantic proximity Read ↗

Antisense oligonucleotide therapeutics for inherited neurodegenerative diseasesSemantic proximity Read ↗

Antisense oligonucleotides for neurodegenerationSemantic proximity Read ↗

Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative DiseasesSemantic proximity Read ↗

Antisense Drugs Make Sense for Neurological DiseasesSemantic proximity Read ↗

Antisense therapies in neurological diseasesSemantic proximity Read ↗

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disordersSemantic proximity Read ↗

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s diseaseSemantic proximity Read ↗

Advancing the battle against Alzheimer's Disease: A focus on targeting tau pathology by antisense oligonucleotideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.